These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Brivio S; Cadamuro M; Fabris L; Strazzabosco M Gene Expr; 2018 Mar; 18(1):31-50. PubMed ID: 29070148 [TBL] [Abstract][Full Text] [Related]
24. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT. Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494 [TBL] [Abstract][Full Text] [Related]
26. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. Nakanuma Y; Uchida T; Sato Y; Uesaka K Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis C Virus Infection and Cholangiocarcinoma: An Insight into Epidemiologic Evidences and Hypothetical Mechanisms of Oncogenesis. Navas MC; Glaser S; Dhruv H; Celinski S; Alpini G; Meng F Am J Pathol; 2019 Jun; 189(6):1122-1132. PubMed ID: 30953604 [TBL] [Abstract][Full Text] [Related]
28. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts. Raggi C; Invernizzi P; Andersen JB J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250 [TBL] [Abstract][Full Text] [Related]
35. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture. Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966 [TBL] [Abstract][Full Text] [Related]
36. Metastatic colon cancer from extrahepatic cholangiocarcinoma presenting as painless jaundice: case report and literature review. Vabi BW; Carter J; Rong R; Wang M; Corasanti JG; Gibbs JF J Gastrointest Oncol; 2016 Apr; 7(2):E25-30. PubMed ID: 27034804 [TBL] [Abstract][Full Text] [Related]
37. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma. Chaiteerakij R; Juran BD; Aboelsoud MM; Harmsen WS; Moser CD; Giama NH; Allotey LK; Mettler TA; Baichoo E; Zhang X; Therneau TM; Lazaridis KN; Roberts LR Cancer Med; 2015 Oct; 4(10):1599-602. PubMed ID: 26276523 [TBL] [Abstract][Full Text] [Related]
38. Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma. Liu T; Zhu G; Yan W; Lv Y; Wang X; Jin G; Cui M; Lin Z; Ren X J Pharmacol Exp Ther; 2020 May; 373(2):279-289. PubMed ID: 32102917 [TBL] [Abstract][Full Text] [Related]
39. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002 [TBL] [Abstract][Full Text] [Related]
40. Current Advances in Basic and Translational Research of Cholangiocarcinoma. Sato K; Baiocchi L; Kennedy L; Zhang W; Ekser B; Glaser S; Francis H; Alpini G Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]